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The generation of sequence-tagged sites (STSs) has been 
proposed as a unifying approach to correlating the disparate 
results generated by genetic and various physical techniques 
being used to map the human genome. We have developed an 
STS map to complement the existing physical and genetic 
maps of 4~16.3, the region containing the Huntington disease 
gene. A total of 18 STSs span over 4 Mb of 4~16.3, with an 
average spacing of about 250 kb. Eleven of the STSs are lo- 
cated within the primary candidate HD region of 2.5 Mb be- 
tween D4S126 and D4Sl68. The availability of STSs makes 
the corresponding loci accessible to the general community 
without the need for distribution of cloned DNA. These STSs 
should also provide the means to isolate yeast artificial 
chromosome clones spanning the HD candidate region. 8 1992 
Academic Press, Inc. 
INTRODUCTION 
The maturing of technologies for manipulating, clon- 
ing, and sequencing DNA has made the mapping and 
sequencing of the entire human genome a feasible goal. 
Several different approaches are being employed to gen- 
erate physical maps of human chromosomes, including 
long-range restriction mapping by pulsed-field gel elec- 
trophoresis, ordering of isolated clones by use of irradia- 
tion-reduced hybrid lines or fluorescence detection- 
based in situ hybridization, and isolation of overlapping 
clone sets (or “contigs”), particularly using cosmids or 
yeast artificial chromosomes. The completion of the ge- 
nome map requires that information from each of the 
different mapping procedures can be readily compared 
and related to the genetic linkage map being constructed 
in parallel. It has been proposed that the use of se- 
quence-tagged sites (STSs), for which specific primer 
pairs yield a characteristic polymerase chain reaction 
product as common signposts on the maps, would fulfill 
the requirement of a “common language” for compari- 
son of the different maps (Olson et al., 1989). 
The ~16.3 cytogenetic band of chromosome 4 is one of 
the more extensively mapped regions of the human ge- 
nome as a result of the search for the defect causing 
Huntington’s disease (Gusella, 1991). The HD gene has 
been confined to a segment of 4~16.3 between D4SlO 
and the telomere (Gilliam et aZ., 1987a). A long-range 
restriction map of this region includes only one gap and 
spans 4.5 Mb from D4SlO to the telomere (B&an et al., 
1990; Bates et al., 1991). Irradiation-reduced hybrids 
have also been applied to mapping 4~16.3 (Cox et al., 
1989; Doucette-Stamm et al., 1991). Numerous phage 
and cosmid clones have been mapped to the region and 
several have yielded DNA polymorphisms, permitting 
construction of a detailed genetic map (MacDonald et 
al., 1989a; Youngman et al., 1989; Allitto et al., 1991a). 
To assist in comparing the evolving physical maps being 
generated with different cell lines and techniques and to 
lay the foundation for isolating overlapping YAC clones 
for the HD candidate region, we have generated a set 
of 18 STSs spanning 4~16.3 at an average spacing of 
250 kb. 
MATERIALS AND METHODS 
Origin of cell lines and clones. HHW416, a human-hamster hybrid 
containing only human chromosome 4, and HHW693, containing only 
human 4pter-4p15.1 and 5p15.1-5cen as part of a naturally occurring 
t(4;5) chromosome with 5q deleted, have been reported previously 
(Wasmuth et al., 1986). Clones used for generation of primer sets have 
been used successfully in Southern blot experiments, and their posi- 
tions on genetic and physical maps have been described previously 
and are listed in Table 1. STSs have been named by adding * followed 
by a sequential identification number to the locus symbol. 
DNA sequencing and preparation of oligonucleotides. DNA se- 
quence was obtained by the procedure of Sanger et al. (1977). Primers 
were synthesized using a Biosearch Cyclone DNA synthesizer or an 
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TABLE 1 
Description of 4~16.3 Sequence-Tagged Sites 





















































5’ CTGGTTCTCAAGAGTGTCTC 3’ 
GCATAATGTTGGTGGCTGCTG3 












5’ AAAGGTAGCAGTCCAGGC 3’ 













192 A 1 
213 B 2 
184 B 3 
159 B 4 
103 A 1 
1066 A 3 
213 B 3 
141 B 3 
243 B 3 
378 A 1 
895 A 1 
202 A 1 
118 A 1 
164 A 1 
230 B 3 
175 A 1 
599 A 1 
267 B 3 
Polymeruse chain reaction. The polymerase chain reaction and cy- 
cling conditions for each primer set are listed in Table 1 as buffer 
mixture A or B and programs l-4. Mixture A consists of 67 mM Tris- 
HCl, pH 8.8; 6.7 mM MgCl,; 16.6 m&f ammonium sulfate; 10 mM 
fl-mercaptoethanol; 10% DMSO; and 1.25 mM dNTPs. Mixture B is 
10 mM Tris-HCI, pH 8.3; 1.5 m&f MgCl,; 50 mM KCl; 0.01% gelatin; 
and 200 pcM dNTPs. Both sets of reactions included 10 ng/pl of each 
primer, 0.02 unit/p1 Tuq DNA polymerase (Perkin-Elmer/Cetus), and 
10 ng/pl genomic DNA and were carried out using one of the following 






Generation of STSs 
Individual clones from a variety of sources have been 
positioned previously on the long-range restriction map 
of 4~16.3 (B&an et al., 1990; Whaley et al., 1991; Bates 
et al., 1991; Lin et al., 1991). The list of those selected for 
sequence analysis to provide a source of STSs is pre- 
sented in Table 1, along with the primer pair, amplifica- 
tion conditions, and predicted size of the amplification 
product for each resulting STS. 
Each of the STS reactions was initially tested using 
DNA from HHW416, a human X hamster hybrid line 
containing only human chromosome 4, or from 
HHW693, a human X hamster hybrid line containing 
4p15.1-4pter as part of a translocation chromosome and 
DNA from tsH1, the hamster parent (Wasmuth et al., 
1986). Since 5p15.1~ken is the only other human DNA 
present in HHW693, the chromosome 4 origin of each 
PCR product could be confirmed using hybrids contain- 
ing either chromosome 4 (HHW416) or chromosome 5 
(HHW599) as the only human DNA. Subsequently, the 
STS reactions were demonstrated also to yield the ex- 
pected fragment as the primary product in amplifying 
human genomic DNA from a variety of sources, such as 
lymphoblastoid cell lines, placenta, or other tissues, and 
as the only product from the clone used to generate the 
corresponding STS. 
Figure 1 shows typical examples of PCR amplification 
products from genomic DNA for several of the STSs 
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FIG. 1. Representative 4~16.3 STS amplification products: Ethi- 
dium bromide-stained gels containing representative PCR products 
from the STSs listed in Table 1. (A) A 6% polyacrylamide gel contain- 
ing the following STS PCR products from HHW693 DNA: lane 1, no 
DNA control; lane 2, D4S166*1; lane 3, D45’10*1; lane 4, D4S115*1; 
lane 5, D4S43*2; lane 6, D45168*1; lane 7, D4S180*1; lane 8, 
D4S95*1. (B) A 1.2% agarose gel containing the products of PCR reac- 
tions for D4S126*1 (lanes l-3), D4S125*1, (lanes 4-6), D4S182*1 
(lanes 7-9), and D4S181*1 (lanes 10-12) using human DNA (lanes 1, 
4,7, lo), HHW416 DNA (lanes 2; 5,9, ll), and hamster DNA (lanes 
3,6,9,12). In A and B, lane M contains HueIII-digested 4X174 DNA. 
reported here. In each case, the major PCR product 
closely matches the predicted size. Occasionally, a frag- 
ment was also amplified from hamster DNA but was 
readily distinguishable from the human product based 
on its size. For example, the -4450-bp product from the 
D4S126*1 STS reaction seen in both the HHW416 and 
hamster lanes is due to amplification of hamster DNA 
(Fig. lB, lanes 2 and 3), as are the -450-bp and -7OO- 
bp products in the D4S180*1 STS amplification (Fig. 
lA, lane 7) and the numerous light bands in the 
D4Sl25*1 amplification (Fig. lB, lanes 5 and 6). 
Location of STSs 
The location and corresponding locus symbol for the 
18 STSs and for eight polymorphisms for which PCR 
assays are available are given in Fig. 2. Two STSs are 
given for the extended D4SlO locus, to which Hunting- 
ton’s disease was first linked (Gusella et al., 1983). 
D4SlO’l was based on a sequence reported by Stapleton 
(1988) to cover polymorphic Hind111 site 2 and a poly- 
morphic HaeIII site detected by phage clone GB. Base 
changes at positions 66 and 152 of the 193-bp PCR prod- 
uct are predicted to be the basis for the Hind111 and 
HaeIII RFLPs, respectively, which could now be assayed 
by digestion of the PCR product with these enzymes. 
D4S10*2 maps 14 kb distal to D4SlO*l, adjacent to but 
not spanning a second polymorphic Hind111 site, re- 
ferred to as Hind111 1. The Iatter can be assayed by PCR 
using a primer set reported by McIntosh et al. (1989) to 
produce a 93-bp product crossing this site. 
D4Sl26*1 was generated using the sequence of a ran- 
dom subclone from cosmid BJ14 (Allitto et a& 1991a). 
This segment falls within a region of increased recombi- 
nation between D4SlO and D4S125 and lies near the 
centromeric limit of the candidate region for HD. 
D4S125*1 was derived from the sequence adjacent to a 
variable number of tandem repeats (VNTR) polymor- 
phism (Nakamura et al, 1988). The VNTR itself can be 
assayed by PCR of a much larger product (1400-2200 
bp) using primers designed by Richards et al. (1991). 
D4S180*1 is located in cosmid L19 at the 04180 locus, 
distal to the region of increased recombination (Lin et 
al, 1991). 
D4S95*1 was designed to span a large single-copy se- 
quence adjacent to the VNTR at this locus (Wasmuth et 
al., 1988). The resulting PCR product overlaps exten- 
sively with the single-copy probe, pBS674D, used in 
Southern blot analysis of the VNTR. It does not overlap, 
however, with the 990 to 1600-bp PCR product of the 
primer set reported by Allitto et al. (1991b) used for PCR 
assay of the VNTR. D4S95*1 lies within the region of 
4~16.3 that displays linkage disequilibrium with HD 
(MacDonald et al., 1991a; Snell et al., 1989; Theilmann 
et al., 1989). 
D4S182*1 and D4S181*1 were derived from subclones 
of cosmids Y12 and L14, respectively (Lin et al., 1991). 
D4S182*1 is adjacent to a VNTR polymorphism that 
has yet to be sequenced. D4S181*1 maps within the 250- 
kb Not1 fragment distal to 048182, but has not yet been 
localized more precisely. This will require the more de- 
tailed restriction map of this segment that will be gener- 
ated from YAC cloning of the region. 
Two STSs are reported for the extended locus 04843, 
which spans 170 kb. The more centromeric D4S43*1 was 
generated from the sequence adjacent to the VNTR 
polymorphism detected by probe pKP1.65 (MacDonald 
et al., 198917). We have recently developed a PCR assay 
for this polymorphism that produces products ranging 
from 184 to 478 bp in size (Horn et al., 1991). Primers for 
D4843”2 were generated from the sequence of the anony- 
mous cDNA, LCD2, reported in Gilliam et al. (198713). 
This STS is located near the telomeric end of 04843, 
approximately 85 kb distal to D4S43*1. Although we 
have not sequenced the PCR product, the correspon- 
dence to the predicted size suggests that it probably con- 
tains little or no intron sequence, but rather derives from 
a single exon. 
D4S166*1 is Iocated in a clone that spans the distal 
breakpoint of an interstitial deletion chromosome that 
splits 4~16.3 into proximal and distal portions and has 
been used in regional somatic cell hybrid mapping pan- 
els (Whaley et al., 1991). FGFR3*1 corresponds to the 
sequence of the single-copy probe pBS385H-A, which 
formerly defined the D4S99 locus (Smith et al., 1988). 
This STS sequence has recently been shown to form 
part of the 3’ untranslated region of the mRNA tran- 
script of a fibroblast growth factor receptor gene. Conse- 
quently, this locus has been renamed FGFR3 (Thomp- 
son et al., 1991). 
D4S168*1 was generated from a single-copy subclone 
of cosmid E4, the cloned segment closest to the centro- 
merit side of the remaining gap in the long-range restric- 
tion map of 4~16.3 (Whaley et al., 1991). D4S115*1 was 
derived from single-copy sequence immediately adjacent 
to another VNTR polymorphism (MacDonald et al., 
1989b). We are currently optimizing a PCR assay for 
this VNTR to complement those developed for the more 
GUSELLA ET AL. 
“H R RR R A FNRC R R RR RR R 
4p telomere 
II II m m  WI n n n n I 
1’9 ;O 
-mm 
14 57 8911 1316 18 23 
2 6 10 12 14 17 21 24?6 
3 15 22 
FIG. 2. Physical map locations of 4~16.3 STS and polymorphism PCR assays. The locations of 18 new STSs (listed in Table l), two site 
polymorphisms, two dinucleotide repeat polymorphisms, and four VNTR polymorphisms for which PCR assays have been established are 
shown below the long-range restriction map of 4~16.3 with a black line to indicate the smallest interval to which each has been localized. The 
corresponding locus numbers are given above the map. The proximal and distal portions of the map are separated by a gap of unknown size, 
where fragments have not yet been visualized. The map of the proximal region is drawn from Bates et al. (1991), Lin et al. (1991), and Whaley et 
al. (1991), and the map of the distal region is drawn from Whaley et al. (1991). Sites (N, NotI; M, MluI; R, NruI) prone to partial digestion are 
shown in lighter typeface. The Huntington disease gene candidate region (Bates et al., 1991) is shown as the cross-hatched portion of the map. 
Square brackets around the Not1 sites at FGFR3 denote the presence of additional sites that have not all been mapped precisely. The PCR 
assays shown in the figure are: 1, D4SIO*l; 2, D4S10*2; 3, D4SlO Hind111 polymorphism assay (McIntosh et al., 1989); 4, D45’126*1; 5, 
D4S125*1; 6,043125 VNTR assay (Richards et al., 1991); 7, D4S180*1; 8,043127 dinucleotide repeat assay (Taylor et al., 1991); 9, D4S95*1; 
10, D4S95 VNTR assay (Allitto et al., 1991b); 11, D4Sl82*1; 12, D4S181*1; 13, D4943*1; 14,04843 VNTR assay (Horn et al., 1991); 16, 
D4S43*2; 16, D4S166*1; 17, FGFR3*1; 18, D4S168*1; 19, D4Sll5*1; 20, IDUA*l; 21, IDUA KpnI polymorphism assay (Scott et al., 1991a); 
22, fDUA VNTR assay (Scott et al., 1991b); 23, D4S232*1; 24, D4S90*1; 25, D4S142*1; and 26, D4S169 dinucleotide repeat assay (Pritchard et 
al., 1991). 
centromeric loci (Allitto et al., in preparation). To- 
gether, D4S168*1 and D4S115*1 may permit the isola- 
tion of YAC clones that will span the gap in the physical 
map, which has not been bridged by other techniques. 
IDUA*l lies within the D4Slll locus, which has re- 
cently been renamed IDUA, encoding ol-L-iduronidase, 
the disease gene in Hurler syndrome (MacDonald et al., 
1991b). Two other segments can be amplified from this 
locus, one crossing a polymorphic f(pnI site (Scott et al., 
1991a) and a second spanning a VNTR polymorphism 
(Scott et al., 1991b). D4S232*1 is from cosmid 114, which 
lies within a 400-kb segment of the telomeric Not1 frag- 
ment of 4p (Whaley et al., 1991), but has not been as- 
signed more precisely due to differences in methylation 
patterns affecting the NruI sites in pulsed-field gel map- 
ping of this region. It is probably located close to PDEB, 
encoding the /3 polypeptide of cGMP phosphodiesterase, 
the human homologue of the mouse rd gene (Weber et 
al., 1991; Bowes et al., 1990). 
D4S90*1 was generated from the single-copy probe 
D5, which detects RFLP with HincII and StuI (Young- 
man et al., 1989). This locus is currently the most telo- 
merit marker that has been formally placed on the link- 
age map of the chromosome. The PCR product crosses 
both a HincII and a StuI site within D5, but we have not 
determined whether either of these represents a poly- 
morphic site. D4S142*1 was derived from 88-18, a sin- 
gle-copy probe detecting an MspI RFLP and located at 
the proximal end of a YAC clone spanning the 100 kb 
that includes the telomere of 4p (Bates et al., 1990). It is 
located proximal to the recently reported D4S169 locus, 
for which a simple-sequence repeat can be assayed by 
PCR (Pritchard et al., 1991). 
DISCUSSION 
The average spacing between our new STSs from 
D4SlO to the telomere is about 250 kb, with the density 
being highest in the HD candidate region. The most no- 
table segments without STSs are the 450 kb between 
D4S180 and D4S95 and the gaps of indeterminate size 
between IDUA, 048232, and D4S90. The first of these 
gaps contains a dinucleotide repeat polymorphism at 
048127 for which a PCR reaction is available (Taylor et 
al., 1992). Filling the gaps between IDUA, D4S232, and 
D4S90 will then require a more specific positioning of 
048232. Also unrepresented is the region between 
D4S168 and D4S115 for which pulsed-field fragments 
have yet to be visualized. It is unlikely that this un- 
mapped gap is large, given the number of random clones 
already isolated from 4~16.3, and it may be possible to 
cross it by isolating YAC clones using the D4S168 and 
D4Sll5 primer sets. 
Taken together with the single-site, dinucleotide re- 
peat, and VNTR polymorphisms for which PCR reac- 
tions have been worked out, the 18 STSs reported here 
bring to 26 the number of PCR assays that could be used 
to screen for YACs in 4~16.3. The 11 new STSs between 
and including D4S126 and D4S168 should prove suffi- 
cient to isolate YAC clones spanning most or all of the 
HD candidate region (Bates et al., 1991). Moreover, the 
density of STSs in the segment can be increased if 
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needed by developing additional primer sets from the 
ends of YACs as they are isolated. We have already iso- 
lated YAC clones using the D4S95 and D4S166 STS 
assays and are pursuing the goal of cloning the HD can- 
didate region and the rest of 4~16.3 in its entirety. Of 
more immediate impact, the development of these 18 
STSs throughout 4~16.3 makes the corresponding loci 
and their surrounding regions readily accessible to the 
entire research community without the cost or difficulty 
of distributing cloned DNAs. 
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